Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eagle Pharmaceuticals
(NQ:
EGRX
)
5.200
-0.040 (-0.76%)
Streaming Delayed Price
Updated: 9:40 AM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eagle Pharmaceuticals
< Previous
1
2
3
4
5
6
Next >
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Eagle Pharma Broadens Acute Care Portfolio With Equity Stake In Respiratory Depression Player
August 09, 2022
Via
Benzinga
Eagle Pharmaceuticals: Q2 Earnings Insights
August 09, 2022
Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:50 AM. Here's what investors need to know about the announcement. Earnings Eagle Pharmaceuticals...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 22, 2022
During Friday's session, 61 companies made new 52-week lows.
Via
Benzinga
Recap: Eagle Pharmaceuticals Q1 Earnings
May 09, 2022
Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q1 earnings results on Monday, May 9, 2022 at 06:50 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim
July 12, 2022
Institutional investors like mutual funds can't get enough of Perrigo stock. It has an A Accumulation/Distribution Rating.
Via
Investor's Business Daily
Short Volatility Alert: Eagle Pharmaceuticals, Inc.
June 15, 2022
On Tuesday, shares of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) experienced volatile short activity. After the activity, the stock price went up +2.39% to $43.35. The overall sentiment for EGRX has...
Via
Benzinga
Eagle Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know
May 04, 2022
Eagle Pharmaceuticals (NASDAQ:EGRX) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
Eagle Pharma Adds Hospital-Based Products With €95M Acacia Pharma Deal
March 28, 2022
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) has agreed to acquire Acacia Pharma Group plc
Via
Benzinga
Eagle Pharma's Q4 Earnings Miss Street View On Lower Product Sales
March 07, 2022
Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) Q4 FY21 sales declined 15% Y/Y to $42.3 million, missing the consensus of $51.08 million. The sales declined primarily...
Via
Benzinga
Eagle Pharmaceuticals: Q4 Earnings Insights
March 07, 2022
Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q4 earnings results on Monday, March 7, 2022 at 06:50 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For March 7, 2022
March 07, 2022
Companies Reporting Before The Bell • Niu Technologies (NASDAQ:NIU) is expected to report quarterly earnings at $0.21 per share on revenue of $144.02 million. •...
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
Eagle Pharmaceuticals's Earnings Outlook
March 04, 2022
Eagle Pharmaceuticals (NASDAQ:EGRX) is set to give its latest quarterly earnings report on Monday, 2022-03-07. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™
February 01, 2022
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals on Track to Support Submission of New Drug Application in Second Quarter 2022 for Landiolol, a Beta-1 Adrenergic Blocker
January 31, 2022
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin
January 18, 2022
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals Provides 2022 Business Update and Announces Launch of Vasopressin
January 05, 2022
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 03, 2022
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals Receives 180 Days of Marketing Exclusivity for Recently Approved Vasopressin
December 29, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals Reports that Par Has Unilaterally Withdrawn Attempt to Halt Launch of Vasopressin
December 20, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
December 15, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron...
Via
Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple...
Via
Benzinga
Exposures
Product Safety
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for...
Via
Benzinga
Exposures
Product Safety
Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021
November 22, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript
November 09, 2021
EGRX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Eagle Pharmaceuticals Reports Third Quarter 2021 Results
November 09, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Eagle Pharmaceuticals to Host Third Quarter 2021 Financial Results on November 9, 2021
October 28, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.